Kiora Pharmaceuticals Q1 2026 Earnings EPS Beat Masks Continued PreRevenue Status as Stock Slips Kiniksa Pharmaceuticals KNSA Q1 2026 Earnings EPS Surprises to the Upside as Stock Dips REAX Q1 2026 Earnings NarrowerThanExpected Loss Fails to Move Shares SVM Q1 2026 Earnings Strong EPS Beat Drives Interest Amid Modest Stock Pullback OFG Bancorp OFG Q1 2026 Earnings Strong EPS Beat Offsets Revenue Uncertainty HCI Group Q1 2026 Earnings EPS Beat Driven by Strong Underwriting Performance